The Asia Pacific Companion Animal Diagnostic Services Market would witness market growth of 8.2% CAGR during the forecast period (2023-2030).
The development of in vitro diagnostic tools and imaging systems aided by introducing micro fluids and miniaturization, among other factors, and is expected to spur the expansion of companion animal diagnostics further. Due to the increasing demand for point-of-care diagnostics (POCD), the market will likely expand. The clinical diagnostics for POCD provide rapid results and can be evaluated directly, saving time.
Radiology (X-rays) and ultrasound services are often used to visualize the internal structures of animals and detect issues such as fractures, tumors, or organ abnormalities. Genetic testing has become increasingly popular for identifying breed-specific health issues and potential genetic predispositions to diseases.
These services are essential for identifying infectious diseases and determining the appropriate treatment. Veterinary pathologists examine tissues and organs to diagnose diseases and evaluate biopsy samples. Telemedicine and digital health platforms have grown, allowing veterinarians to consult with specialists or remotely monitor pets' health. Companion animal diagnostic services often work with pharmaceutical companies to develop treatments and therapies for various pet health conditions.
As veterinary specialization grows in APAC, pet owners have better access to specialized diagnostic services. They seek out specialized veterinary clinics and specialists who provide in-depth expertise and advanced diagnostics for specific conditions. The presence of board-certified specialists in the APAC region enhances the overall quality of care for companion animals. The growth of veterinary specialization in APAC has increased educational opportunities for veterinarians seeking specialized training, promoting a culture of continuous learning and expertise. Due to the aforementioned elements, the regional market is expected to rise significantly in the coming years.
The China market dominated the Asia Pacific Companion Animal Diagnostic Services Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $788.5 million by 2030. The Japan market is registering a CAGR of 7.5% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 8.9% during (2023 - 2030).
Based on Type, the market is segmented into Point-of-Care (POC) and Laboratory-based. Based on Animal Type, the market is segmented into Dogs, Cats, Horses and Others. Based on Testing Category, the market is segmented into Clinical Chemistry, Microbiology, Parasitology, Histopathology, Cytopathology, Hematology, Immunology & Serology, Imaging, Molecular Diagnostics and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Companion Animal Diagnostic Services Market is Predict to reach $10.4 Billion by 2030, at a CAGR of 7.4%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Zoetis, Inc., IDEXX Laboratories, Inc., Mars Inc., Fujifilm Holdings Corporation, Embark Veterinary, Inc., Thermo Fisher Scientific Inc., Patterson Companies, Inc., Randox Laboratories Limited, CVS Group Plc, and Neogen Corporation
By Type
By Animal Type
By Testing Category
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
